Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

Opioid agonist adverse event reports that FDA received for the drugs of this class

Kind of class
Pharmacologic class (FDA Established Pharmacologic Class)
Drug pages
42

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

Opioid agonist is a pharmacologic class: an FDA Established Pharmacologic Class. The class has 42 drug pages on this site.

From January 2004 to June 2026, FDA received 965,051 adverse event reports that name a drug of the class. In these reports the drug is a suspect or interacting product. A report that names two drugs of the class counts one time for each.

FDA received 20,413 reports in the 12 months to June 2026 and 25,028 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 20,413 (1.5%) name a drug of the class. Reports from lawyers were 43.3% of the reports that name a drug of the class and 2.6% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

Pharmacologic class

The Established Pharmacologic Class (EPC) of FDA is the class on the label of a drug. The site puts a drug in the class that its reports have most often.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs of the class

The rows are in order of name. A brand name and its generic name are separate rows, because reporters name them separately.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drug pages of the class Opioid agonist, in order of name
DrugName typeReportsReports, 12 months to June 2026
Acetaminophen and codeineGeneric name7,248493
Acetaminophen and codeine phosphateGeneric name5310
Codeine sulfateGeneric name2,15464
DemerolMeperidine hydrochlorideBrand name5,360285
DilaudidHydromorphone hydrochlorideBrand name64,191173
EndocetOxycodone and acetaminophenBrand name9,991146
FentanylGeneric name53,6563,292
Fentanyl citrateGeneric name15,039270
Hydrocodone bitartrateGeneric name11,473297
Hydrocodone bitartrate and acetaminophenGeneric name59,052170
Hydromorphone hydrochlorideGeneric name11,824769
Hysingla ERHydrocodone bitartrateBrand name30,7036
ImodiumLoperamide hydrochlorideBrand name5,968326
Imodium A-DLoperamide hydrochlorideBrand name3,46368
Loperamide hydrochlorideGeneric name5,180707
Meperidine hydrochlorideGeneric name1,01819
MethadoneGeneric name24,293909
Methadone hydrochlorideGeneric name5,129318
MethadoseMethadone hydrochlorideBrand name3,67229
MorphineGeneric name28,4211,421
Morphine sulfateGeneric name60,0921,577
MS ContinMorphine sulfateBrand name52,12855
NorcoHydrocodone/acetaminophenBrand name24,66142
NucyntaTapentadol hydrochlorideBrand name27,575127
OxycodoneGeneric name35,6712,853
Oxycodone and acetaminophenGeneric name24,919112
Oxycodone hclGeneric name4,7000
Oxycodone hydrochlorideGeneric name113,2202,598
OxyContinOxycodone hydrochlorideBrand name146,263584
Oxymorphone hydrochlorideGeneric name11,54412
PercocetOxycodone hydrochloride and acetaminophenBrand name57,793198
Promethazine hydrochloride and codeine phosphateGeneric name3,5496
Remifentanil hydrochlorideGeneric name66576
RoxicodoneOxycodone hydrochlorideBrand name14,72046
Sufentanil citrateGeneric name78792
TapentadolTapentadol hydrochlorideBrand name2,005156
Tapentadol hydrochlorideGeneric name82711
Tramadol hclGeneric name5,79919
Tramadol hydrochlorideGeneric name27,4471,952
Tramadol hydrochloride and acetaminophenGeneric name55722
UltivaRemifentanil hydrochlorideBrand name61320
XtampzaOxycodoneBrand name1,15093

Reaction lookup

These are the reaction terms that the reports of the class record. Type a term or a plain word to find its count.

What this list leaves out

The table lists the 4,125 reaction terms that 5 or more reports record. A term with fewer than 5 reports is not in the table.

The site keeps reaction terms for 963,107 of the 965,051 reports (99.8%).

The reports of the other years are not in the counts.

So a count in the table can be lower than the count of FDA.

The table shows the first 50 of 4,125 terms.

Reaction terms in the reports that name a opioid agonist drug, most reports first
Reaction term (MedDRA) and plain meaningReportsShare of the 965,051 reports
Drug dependencedependence on a medicine350,67436.3%
Overdosea dose above the recommended amount232,03224%
Painpain, site not specified168,21217.4%
Deaththe patient died; cause not stated by this term155,89016.2%
Emotional distress138,96314.4%
Toxicity to various agentspoisoning or toxic effect of one or more substances123,37912.8%
Drug withdrawal syndromesymptoms on stopping a medicine108,53311.2%
Dependence65,9516.8%
Drug abusemisuse of a medicine63,8546.6%
Drug ineffectivethe medicine did not work as expected38,0613.9%
Anxiety33,9883.5%
Drug withdrawal syndrome neonatal33,3583.5%
Depressionlow mood31,0953.2%
Drug hypersensitivityan allergic-type reaction (the term names a medicine)30,0073.1%
Foetal exposure during pregnancythe unborn baby was exposed to the medicine28,8313%
Nauseafeeling sick27,1152.8%
Vomitingbeing sick23,4562.4%
Developmental delayslower development in a child19,6212%
Learning disability19,5682%
Fatiguetiredness18,9962%
Off label useused for a purpose or in a way not on the label18,9422%
Ill-defined disordera condition that was not clearly described18,4421.9%
Headachehead pain18,0511.9%
Maternal exposure during pregnancythe mother took the medicine during pregnancy16,9921.8%
Dyspnoeashortness of breath16,9391.8%
Completed suicidedeath by suicide16,9021.8%
Constipation16,4611.7%
Disability16,3501.7%
Confusional stateconfusion16,1111.7%
Withdrawal syndrome16,0431.7%
Injurya physical injury15,4701.6%
Insomniadifficulty sleeping14,8671.5%
Mental disorder14,4301.5%
Somnolencedrowsiness14,4301.5%
Diarrhoealoose or frequent stools14,3971.5%
Rashskin rash14,0301.5%
Malaisegeneral feeling of being unwell13,7141.4%
Arthralgiajoint pain13,2961.4%
Dizzinesslight-headedness or unsteadiness13,2541.4%
Pyrexiafever12,9371.3%
Pruritusitching12,3011.3%
General physical health deteriorationgeneral decline in health12,0441.2%
Hypertensionhigh blood pressure11,5381.2%
Drug interactionan interaction between medicines11,3601.2%
Accidental overdosean accidental overdose11,2081.2%
Hypersensitivityan allergic-type reaction11,0711.1%
Drug intolerancethe medicine was not tolerated10,9791.1%
Joint swellinga swollen joint10,9621.1%
Falla fall10,9461.1%
Astheniaweakness or lack of energy10,9351.1%

Download all 4,125 terms of the class (CSV)

The counts add to more than 965,051 reports, because one report can record more than one term. FDA says:

No individual drug is connected to any individual reaction. When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Reports by month

Reports that name a opioid agonist drug, by month, five years to June 2026
050,000100,00020222023202420252026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Outcomes, patients and reporters

Outcomes in the reports of the class Opioid agonist
OutcomeReportsShareShare as a bar
Death344,04335.7%
Life-threatening28,7223%
Hospitalization (initial or prolonged)121,28212.6%
Disability or Permanent Damage89,0999.2%
Congenital Anomaly/Birth Defect17,3321.8%
Other Serious (Important Medical Events)605,15662.7%
Not serious80,1358.3%

An outcome in a report is not proof that a drug was the cause. The reporter gives the outcome, and FDA does not verify it. A report can have more than one outcome. FDA says:

The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Age of the patient in the reports of the class Opioid agonist
AgeReportsShareShare as a bar
Under 23,8360.4%
2 to 112,8350.3%
12 to 175,1790.5%
18 to 4492,5539.6%
45 to 6481,6968.5%
65 to 7428,9513%
75 and over23,2672.4%
Age not given726,73475.3%
Type of reporter in the reports of the class Opioid agonist
ReporterReportsShareShare as a bar
Physician95,5289.9%
Pharmacist26,9782.8%
Other health professional100,25610.4%
Lawyer417,80643.3%
Consumer or non-health professional313,21632.5%
Not given11,2671.2%

Official pages

The site checked these addresses on . The links open in a new tab.

Cite this page

Reported Reactions. Opioid agonist: adverse event reports that FDA received. https://reportedreactions.com/class/opioid-agonist/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The class of a drug is the Established Pharmacologic Class that openFDA attaches to its reports most often. When the reports have none, it is the class in the NDC Directory. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Which drugs are in the Opioid agonist class on this site?

Acetaminophen and codeine, Acetaminophen and codeine phosphate, Codeine sulfate, Demerol, Dilaudid, Endocet and 36 more, in order of name. The class of a drug comes from the pharmacologic class (EPC) on its FDA label.

Can the table of drugs rank the drugs?

No. FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Drugs also differ in the conditions that they treat and in their time on the market.

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.